Clinical Trial Supplies Market Size 2024-2028

The global clinical trial supplies market size is estimated to grow by USD 1.31 billion, at a CAGR of 8.65% between 2023 and 2028. Biopharma is experiencing significant growth, driven by several key factors. Firstly, there is a rise in the demand for innovative biopharmaceutical products, fueled by advancements in medical research and an increasing focus on personalized medicine. Additionally, government initiatives aimed at promoting clinical research further stimulate industry expansion, providing funding and support for research and development activities and clinical trial support services. Moreover, the regulation of clinical trials in regional markets ensures compliance with safety and ethical standards, fostering trust and confidence in biopharmaceutical products among healthcare professionals and consumers. These interconnected trends underscore the dynamic landscape of the biopharmaceutical industry, where collaboration between government agencies, research institutions, and industry stakeholders drives innovation and advances healthcare outcomes. As regulatory frameworks evolve and investment in research increases, the market for biopharmaceuticals is poised for continued growth, offering opportunities for improved treatments and medical breakthroughs in various therapeutic areas.

What will be the Size of the Clinical Trial Supplies Market During the Forecast Period?

To learn more about this market report, Download Report Sample

The global clinical trial supply market is experiencing a period of rapid evolution, driven by a combination of factors, including increasing complexity of clinical trials, advancements in technology, and growing demand for clinical research services. Key trends shaping the industry include a shift towards outsourcing of clinical trial supply chain activities, the growing importance of data management and analytics, and a focus on risk mitigation and continuity planning. As clinical trials become more complex and global in scope, there is a rising demand for specialized clinical trial supply services, including sourcing, logistics, and storage of clinical trial materials. Additionally, the increasing use of technology, such as blockchain and artificial intelligence, is transforming the way clinical trial supply chains are managed, enabling greater efficiency and transparency. The clinical trial supply industry is also adapting to evolving regulatory frameworks and industry standards, with a focus on quality assurance, compliance, and patient safety. Overall, the global clinical trial supply market presents both challenges and opportunities for businesses, as they navigate the evolving landscape and strive to meet the changing needs of the pharmaceutical and biotechnology industries.

Clinical Trial Supplies Market Segmentation

The clinical trial supplies market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user Outlook 
  • Pharmaceutical industry
  • Biologics industry
  • Medical device industry

• Type Outlook 
  • Phase III
  • Phase II
  • Phase IV and BE/BA studies
  • Phase I

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the World (ROW)
    • Brazil 
    • Australia
    •  Argentina

The market share growth by the pharmaceutical industry segment will be significant during the forecast period. Drug discovery informatics and bringing a new drug to market are complex processes and require clinical trials to test the safety, effectiveness, and performance of new drugs. In addition, stringent regulations developed by the FDA to ensure the safety and effectiveness of new and personalized drugs are increasing the need for clinical trials for pharmaceuticals. 

Get a glance at the market contribution of various segments. Download PDF Sample

The pharmaceutical industry segment was valued at USD 907.30 million in 2018. The need to develop new drugs and introduce new generic and brand-name drugs in the market is constantly increasing due to the proliferation of epidemic diseases and chronic diseases, driving the demand for chronic disease management. Furthermore, there is a growing need for clinical trial supplies from the pharmaceutical industry to provide logistics and warehousing facilities for manufacturers and CROs. As a result, clinical trial supplies suppliers have more opportunities to provide services such as logistics and supply chain management, helping to increase the share of the pharmaceutical industry in the market during the forecast period. The market forecasting report includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.

Regional Analysis

For more insights about the market share of various regions, Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The prevalence of chronic diseases is increasing, the number of clinical trials is increasing, and the number of life science research activities is increasing in the US and Canada. The US and Canada represent the largest continental pharmaceutical markets in the world. Pharmaceutical companies are one of the major customers for clinical trial supplies due to the large number of clinical trials conducted to validate their new drug discoveries and get them out in the market.

Furthermore, the lack of divergence between regional regulatory policies and the FDA is a key factor driving the increased number of clinical trials in this region. Besides, the growing demand for outsourcing clinical trials is also boosting the need for clinical trial services, including logistics, warehousing, and the safety of clinical trial supplies. Thus, such factors will drive the growth of the market in this region during the forecast period.

Clinical Trial Supplies Market Dynamics

The market plays a pivotal role in advancing medical research and treatment therapies for a wide range of conditions, including cancer cases. From cold storage and distribution to storage & delivery logistics, suppliers ensure the safe and timely provision of medical devices and traditional cancer treatment therapies. Amidst the rising incidence of diseases, CROs (contract research organizations) collaborate with Pharma R&D clinical trials to study the efficacy of new treatments, emphasizing the importance of buying behaviour and blinding protocols in maintaining research integrity. As breakthroughs in genetics and biotechnology reshape healthcare, the clinical trial supplies market remains a cornerstone of progress. Analyzing conference and webinar materials alongside buying behavior data can provide insights into the prevalence of diseases and the effectiveness of treatments, including follow-up rates in registered clinical trials, particularly significant in addressing conditions like cardiovascular disease, driving the demand for cardiovascular therapeutics.

The global clinical trial supply market is undergoing a period of significant transformation, driven by a confluence of factors, including increasing complexity of clinical trials, advancements in technology, and growing demand for clinical research services. Key trends shaping the industry include a shift towards outsourcing of clinical trial supply chain activities, the growing importance of data management and analytics, and a focus on risk mitigation and continuity planning. As clinical trials become more complex and global in scope, there is a rising demand for specialized clinical trial supply services, including sourcing, logistics, and storage of clinical trial materials. Additionally, the increasing use of technology, such as blockchain and artificial intelligence, is transforming the way clinical trial supply chains are managed, enabling greater efficiency and transparency. The clinical trial supply industry is also adapting to evolving regulatory frameworks and industry standards, with a focus on quality assurance, compliance, and patient safety. Overall, the global clinical trial supply market presents both challenges and opportunities for businesses, as they navigate the evolving landscape and strive to meet the changing needs of the pharmaceutical and biotechnology industries.

Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. Market forecasting with holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Key Market Drivers

The growth of the biopharmaceutical industry is one of the key factors driving the growth of the market. The dynamics of the biopharmaceutical industry are changing as the pharmaceutical industry looks to the biopharmaceutical industry to discover new drugs and biosimilars introduced to the market by new global participants. Biopharmaceuticals have reduced the number of deaths from cancer and HIV/AIDS in the last few years, which has led to an increase in the use of biopharmaceuticals in the global market.

Moreover, the significant expansion of the global biopharmaceutical market has led to the development of many other industries, such as contract research, contract manufacturing, consumables, and pharmaceuticals. as well as clinical trials. The research and production of drugs and biologics involves clinical trials to ensure a product's safety, effectiveness, and minimal side effects. As a result, the growing biopharmaceutical industry leads to clinical trial supplies market growth during the forecast period. 

Significant Market Trends

An increase in studies focusing on the pharmaceutical industry is one of the primary trends in the market. Increasing clinical research into several types of cancer has contributed to a greater emphasis on personalized medicine as pharmaceutical companies seek to invest in the latest market trends. Government funding is also contributing to the growth of personalized medicine. Precision medicine requires different ways to test interventions. Researchers need to probe a multitude of factors, such as genetics and environmental factors, that determine a person's response to treatment.

Furthermore, due to the substantial growth of drug-targeted studies, the need for further clinical trials has increased in the last few years. Newly approved drugs and applied drugs must be safe, targeted, and have long-term effectiveness, as guaranteed by clinical trial services. As a result, the growing number of clinical trial services to ensure the safety of new drugs has fueled the growth and development of clinical trial supplies, which will drive clinical trial supplies market growth during the forecast period. 

Major Market Challenges

The high cost of clinical trials is a challenge that affects market growth. Clinical trials have changed over the years, and as a result, there are growing concerns about the growing cost of clinical trials. Another challenge is patient recruitment, and studies by the Centers for Disease Control and Prevention (CDC) have shown that of all clinical trials registered in the US, about 48-50% of Clinical trials were delayed due to problems during implementation, patient recruitment or some trials could not find patient recruitment. In addition, increasing awareness of the clinical trial process will lead to increased participation of recruited patients in the trial. Pharmaceutical companies should emphasize patient education rather than persuasion.

Furthermore, the cost of developing and manufacturing a vaccine depends on the type of vaccine, the level of innovation, the target disease, and the regulatory agency. The total cost of developing and manufacturing a vaccine could exceed USD 50 million. Each phase of a vaccine clinical trial has a different cost structure. For example, a phase I clinical trial development can range from USD 2 million for a convertible product to USD 60 million for an innovative product, with an average cost of USD 12 million for essential chemicals, production, and control (CMC) essentials. Therefore, increasing clinical trial costs may hinder clinical trial supplies market growth during the forecast period.

Customer Landscape

The clinical trial supplies market forecast report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the clinical trial supplies market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Key Clinical Trial Supplies Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Catalent Inc.: The company offers clinical trial supplies services such as package material management, QC test, GMP release, and product delivery.

Ancillare LP, Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd.,  Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PCI Pharma Services, PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Precision Medicine Group LLC, Thermo Fisher Scientific Inc., and Vertical Pharma Resources Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is pivotal in facilitating the advancement of medical technologies, particularly in areas like oncology and rare diseases. With the rise of biological drugs and biologics, the demand for biological trial supplies and nanoparticle-based drug delivery systems is escalating. Cold chain capabilities and cold storage distribution play a critical role in maintaining the integrity of blood products and vaccines during transportation. However, challenges like the high cost of drug development and failure of clinical trials underscore the importance of regulatory support and investment in drug development. Technological advancements are driving innovations in electronic records and signatures, streamlining processes, and ensuring good clinical practices are followed across clinical research activities and clinical trial support. Amidst globalization, collaboration among contract research organizations (CROs) and clinical research organizations is crucial in overcoming hurdles and meeting the diverse needs of key stakeholders in the pharmaceutical industry.

Further, in medical research, the market plays a pivotal role in facilitating the development and approval of novel pharmaceutical drugs, including biologics and biosimilars. Ensuring the integrity and efficacy of these supplies requires meticulous attention to detail, including cold chain distribution and storage and distribution to maintain potency. Challenges such as hindrance in drug approval and limitations in clinical trials necessitate close adherence to FDA regulations and protection of human subjects. Moreover, with the decentralization of clinical trials, logistics become even more crucial, emphasizing the need for efficient healthcare logistics and skilled labourers. Collaboration among CROs and industrial collaborations drives innovation in manufacturing processes and packaging, advancing the novel drug development process while ensuring labeling compliance and regulatory support.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Clinical Trial Supplies Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size and its contribution to the market in focus on the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies' position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies